GET A PIECE OF CURENTA
Reimagining the Long-Term Pharmacy
$101,131.92 Raised
Reasons to Invest
- Curenta re-imagines the long-term pharmacy industry by challenging its core components and up-scaling its service level while saving on operations costs.
- Long-term care (LTC) consumes more than US $23 billion of medications annually and is growing at a staggering 6.8% a year. We have grown by 7x in the last 12 months. In our first year of operations, we have made almost US $3.59 Million in annualized sales (ARR) as of Dec 2021. (2021 figures unaudited, preliminary, and subject to change)
- Key investors and Advisors include
- Amir Barsoum; A serial entrepreneur who built one of the biggest global digital healthcare companies operating in 10 countries serving more than 20 million patients.
- Ihab Dorotta; Chief, quality, and patient safety officer of Loma Linda University Hospital (LLUH), was chosen as one of the top 50 patient safety experts to know in the country by Becker’s and the best in the inland empire. Has extensive experience in the long-term care space.
Overview
Curenta: Reimagining the Long-term Pharmacy
Our proprietary technology streamlines it all - from receiving the orders, to the preparation of medication, to the delivery - we operate with complete transparency of the steps.
We’re here to reduce wasted time, energy, and money in the process.
This means:
- Reduced workload for the facility nurses by 50%
- Improved nurse/prescriber relationship by eliminating the need for frequent phone calls
- Eliminated pharmacy mistakes which results in fewer medication errors
- Improved communication between the prescriber and the pharmacy which results in faster delivery
- Increased patient satisfaction since they receive their medications faster and more reliably
The Problem
Lots of Issues When it Comes to Long-term Care Resources
This is why we’ve narrowed our target issues to these main factors:
Not to mention, outdated communication tools with pharmacies along with delayed medication delivery forces facilities to have unnecessary costs along with increased patients’ dissatisfaction.
THE Market
Long-term Pharmacy Market is on the Rise
And that means our market size is $23 billion, with a CAGR of 6.8%.
Here’s why:
The Solution
Say Hello to Connected APIs and On-Demand Delivery
We are a meds management tool and connected-APIs pharmacy network - coupled with on-demand delivery to turnaround in just 3-4 hours.
Let’s walk through what that looks like:
A facility uses our medication management tool to order medications for their patients, all to reduce the chance of medication errors while saving time.
Once the pharmacy receives the orders, our system organizes and sorts them based on our proprietary AI Algorithm to make sure that everyone involved in preparing the medications knows which orders they should be working on first.
As the pharmacies’ teams prepare the medications, the delivery app creates routes automatically considering the 3-hours delivery turnaround time, traffic, delivery address, and pushes notifications to our on-demand fleet of drivers, and whoever accepts the route picks up the medication from that store, and delivers the medications.
Curenta has been a huge asset for any facility in terms of visibility and efficiency. The entire operation is streamlined, which means that physicians, nurses, and med-techs have more time to spend on patient care rather than administrative tasks.
Curenta’s unique features make it easy to manage all aspects of the prescription fulfillment:
- Check patient medication history
- Submit prescriptions through the platform
- Track each order as it moves through the system
There are a few reasons why we stand out against the crowd.
1. Curenta has speeded up most of the processes for the nurses and the pharmacy, using automation and AI in the ordering, billing, filling and shipping processes, resulting in high patients’ satisfaction. While in today’s traditional pharmacy most of the orders are still communicated through faxes, resulting in high rates of medication errors and late deliveries. (Source)
2. After the pandemic, nursing staff and caregivers are often overwhelmed by all the tasks they must do on a daily basis to ensure that their patients receive the proper care they require. Instead of communicating manually with pharmacists, doctors, and hospitals, we can now automate these processes by using an online prescription ordering system, saving them a lot of time that was previously wasted. (Source, Source)
3. The traditional pharmacy operations are always hidden, no one from the facility side knows anything about their orders unless the pharmacy teams are proactively communicating with the facility. This is not the case with Curenta, where every single step through the process is trackable with full transparency. Nurses and patients can easily track their prescriptions, communicate with the pharmacy team, know the delivery ETA (estimated time of arrival) without calling or spending their precious time trying to figure it.
We make money through dispensing medications to LTC facilities and hospices from our own stores, and network of stores.
Why Invest
Our Vision: To Re-imagine The Pharmacy
In today’s world, where technology plays an important role, there are multiple processes involved in medication management that can be automated using our software applications. These include prescription processing, dispensing, inventory management, patient engagement, etc.
As we look forward, we want to be able to connect our customers; facilities, and patients to a decentralized marketplace where their orders go straight to the closest Curenta store with available stock and automatically bill their prescriptions using artificial intelligence (AI). It could improve efficiency, accuracy, and cut down on medication errors (48% in normal cases), and speed up things for pharmacies and nurses.
Our vision is to build a fully automated network of stores, all connected by our technology, to serve the elderly population with fast, simple, and affordable services.
We have already poised ourselves to be a great market fit, which is reflected in the hyper-growth rate of $3.59 million in ARR we have already hit in our first 12 months.*
The next milestone is to execute the business plan by having more stores owned by Curenta to cover different geographical locations and making sure of the fulfillment side. This also means the implementation of “Dark Pharmacies” concept meaning a network of Pharmacies owned and managed by other pharmacists to expand our market share in a faster way.
*Please note these financials have not been audited or reviewed by our CPA and are subject to change. Please refer to the risk factors of our offering materials.
We are ready for takeoff in the pharmacy industry. We’re here to utilize the technology of today, and implement these systems which have historically lacked such tools. We want to make life easier for patients, nurses, and pharmacies alike.
Join us on our mission!
ABOUT
HEADQUARTERS
23141 Verdugo Dr, Suite 103
Laguna Hills, CA 92653
WEBSITE
View Site
Curenta - is an online pharmacy serving long-term care providers. Curenta is reimagining pharmacy, one vertical at a time. Long-term care is a forgotten vertical with its unique complexity where Curenta is solving communication and delivery issues between facilities and pharmacies. With the network of stores, Curenta can turn around orders in an astounding 3 hours, saving money on unused medications and wasted nurses’ time.
TEAM
Ramy Barsoum Mikhail
Chief Executive Officer
A CA licensed pharmacist and MBA degree holder from MsM with 15+ years of experience in retail and Long-Term Care pharmacies & 5 years leading a 12 pharmacies-consortium focusing on long-term care, serving 15,000 beds.
Ryan Soo Hoo
Director of Business Development
A CA licensed PharmD and published clinical oncology researcher with pharmacy enterprise sales experience, focused on novel oncology drug-delivery systems. Utilizing his insight and experience in inpatient and outpatient pharmacy, Ryan is leading the team in building foundational business strategies with Long-Term Care facilities and Treatment Centers.
Ghada ElWahsh
Head of Product
Nancy Yani
Operations Manager
Armstrong Chu
Pharmacist In Charge (PIC)
A CA licensed PharmD with 5 years long-term care pharmacy experience. Armstrong is leading the pharmacy team in the daily interactions with the Long-Term Care facilities.
Amir Barsoum Mikhail
Chairman
Mario Karras
Board Observer
TERMS
Curenta
Overview
PRICE PER SHARE
$16
DEADLINE
May 1, 2022
VALUATION
$28.8M
FUNDING GOAL
$10k - $1.07M
Breakdown
MIN INVESTMENT
$224
MAX INVESTMENT
$106,992
MIN NUMBER OF SHARES OFFERED
625
MAX NUMBER OF SHARES OFFERED
66,873
OFFERING TYPE
Equity
ASSET TYPE
Common Stock
SHARES OFFERED
Common Stock
Maximum Number of Shares Offered subject to adjustment for bonus shares
*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.
Voting Rights of Securities Sold in this Offering
Voting Proxy. Each Subscriber shall appoint the Chief Executive Officer of the Company (the “CEO”), or his or her successor, as the Subscriber’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with this instrument and on behalf of the Subscriber, (i) vote all Securities, (ii) give and receive notices and communications, (iii) execute any instrument or document that the CEO determines is necessary or appropriate in the exercise of its authority under this instrument, and (iv) take all actions necessary or appropriate in the judgment of the CEO for the accomplishment of the foregoing. The proxy and power granted by the Subscriber pursuant to this Section are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the Subscriber is an individual, will survive the death, incompetency and disability of the Subscriber and, so long as the Subscriber is an entity, will survive the merger or reorganization of the Subscriber or any other entity holding the Securities. However, the Proxy will terminate upon the closing of a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933 covering the offer and sale of Common Stock or the effectiveness of a registration statement under the Securities Exchange Act of 1934 covering the Common Stock.
Investment Incentives and Bonuses*
Early Bird
Friends and Family - First 72 hours | 15% bonus shares
Super Early Bird - Next 72 hours | 10% bonus
Early Bird Bonus - Next 7 days | 5% bonus shares
Volume
Tier 1 perk - (Invest $1000+ and receive 5% bonus shares)
Tier 2 perk - (Invest $2,500+ and receive 10% bonus shares)
Tier 3 perk - (Invest $5,000+ and receive 15% bonus shares and membership in our Investor Club which allows you to receive special investor updates, and attend Q&A sessions)
Tier 4 perk - (Invest $10,000+ and receive 15% bonus shares and membership in our Investor Club and an in-person meeting with the leadership team).
*All perks occur when the offering is completed.
The 10% StartEngine Owners' Bonus
Curenta Enterprise Corp. will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.
This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Stock at $16/share, you will receive 110 Common Stock, meaning you'll own 110 shares for $1,600. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.
This 10% Bonus is only valid during the investor's eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.
Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.
Insider Investment Notice
Officers, directors, executives, and existing owners with a controlling stake in the company (or their immediate family members) may make investments in this offering. Any such investments will be included in the raised amount reflected on the campaign page.
Irregular Use of Proceeds
We will not incur any irregular use of proceeds.
PRESS
ALL UPDATES
REWARDS
JOIN THE DISCUSSION
0/2500
Kirtson Thompson
2 years ago
You mentioned that you need 23 stores to fully target your intended market starting from 1 already in 2021. Do you have an alternative strategy to accelerate buildout of the store roofline BEFORE 2025? If it is a question of funding VCs ca easily facilitate this fast runway. I guess my question is why reg CF at this point when you have ARR of $3.5MM already and poised to grow.
2
1
Kirtson Thompson
2 years ago
I definitely like the potential here however my major concern here is the amount of dilution in future given this is Reg CF at $16/share common equity. Any protections for us early potential investors?
1
0
Michael Asare-Sawiri
2 years ago
Can you put out a short video to explain EXACTLY what you do? How does Curenta make fast delivery? What exactly do you do?
2
1
Adam Forster
2 years ago
Hello. Since 1Q21, revenue per facility seems to be declining, Why? If you are able to deliver drugs so timely, why are you limiting your target market to LT Care? Thanks.
0
0
Girish Amin
2 years ago
Congrate on ur CF campaign launch on SE. I like what I see. What is your view on NowRx in competitive landscape? I don't see them listed in your chart.
Thanks!
2
0
Benjamin Landman
2 years ago
Are 2021 Financials available? If not yet, when will they be available? How can we obtain a copy?
1
5
HOW INVESTING WORKS
Cancel anytime before 48 hours before a rolling close or the offering end date.
WHY STARTENGINE?
REWARDS
We want you to succeed and get the most out of your money by offering rewards and memberships!
SECURE
Your info is your info. We take pride in keeping it that way!
DIVERSE INVESTMENTS
Invest in over 200 start-ups and collectibles!
With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.
With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.
At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.
Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.
StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.
For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.
For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.
Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.
Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.
Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.
Youssef Fawzy
2 years ago
0
0